Fig. 1: Neurotransmitter autoantibodies are reduced after apheresis. | Molecular Psychiatry

Fig. 1: Neurotransmitter autoantibodies are reduced after apheresis.

From: Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis

Fig. 1

Antibodies against the β1 and β2 adrenergic receptors (AdR) and the M3 and M4 acetylcholine receptors (AChR) were measured in the blood of Long-Covid patients (n = 27) pre- and post-apheresis. Reference values are marked with a dotted line. RAA: receptor autoantibodies. ***P < 0.001 (paired two-sided t-test).

Back to article page